Geographic Atrophy Treatment Innovations: How Genentech, Santen, and Regeneron Are Revolutionizing the Ophthalmology Market
Geographic Atrophy Market Overview by Country
United States (USA): The United States geographic atrophy market globally, owing to its advanced healthcare infrastructure, high prevalence of age-related macular degeneration (AMD), and robust research and development activities. Geographic atrophy (GA) is a primary cause of vision loss in individuals over 50, affecting approximately 1.3...
0 Comments
0 Shares
100 Views